Transcriptomics

Dataset Information

0

A novel class of alternative 3’-terminal exons is involved in cell-cycle regulation by topoisomerase inhibitors


ABSTRACT: Alternative 3’-terminal exons, which use intronic polyadenylation sites, are generally unconserved and lowly expressed, while the main gene products end in the last exon of genes. In this study, we discover a class of human genes, where the last exon appeared recently during evolution, and the major gene product uses an alternative 3’-terminal exon corresponding to the ancestral last exon of the gene. This novel class of alternative 3’-terminal exons are down-regulated on a large scale by doxorubicin, a cytostatic drug targeting topoisomerase II, and play a role in cell cycle regulation, including centromere-kinetochore assembly. The RNA-binding protein, HuR/ELAVL1 is a major regulator of this specific set of alternative 3’-terminal exons. HuR binding to the alternative 3’-terminal exon in the pre-messenger RNA promotes its splicing, and is reduced by topoisomerase inhibitors. These findings provide new insights into the evolution, function and molecular regulation of alternative 3’-terminal exons.

ORGANISM(S): Homo sapiens

PROVIDER: GSE53474 | GEO | 2014/02/04

SECONDARY ACCESSION(S): PRJNA232113

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-02-04 | E-GEOD-53474 | biostudies-arrayexpress
| PRJNA232113 | ENA
| PRJNA153883 | ENA
2018-01-01 | E-MTAB-4018 | biostudies-arrayexpress
2011-08-19 | GSE29778 | GEO
2021-08-01 | GSE118981 | GEO
2019-02-02 | GSE113628 | GEO
2012-11-21 | GSE42421 | GEO
2020-07-01 | E-MTAB-4017 | biostudies-arrayexpress
2011-08-18 | E-GEOD-29778 | biostudies-arrayexpress